Related Funds
Fund Name | Location |
Abstraction Capital | Kansas City, Missouri, United States |
Adapt Low Carbon Group | Norfolk, Norwich, United Kingdom |
Ambina Partners | Connecticut, Greenwich, United States |
Amigo Health | Grapeview, United States, Washington |
aMoon2 Fund | - |
BACS-Innov | - |
CMG-SDIC Capital Management | Beijing, Beijing, China |
DoubleRock | California, Menlo Park, United States |
ES Investor | Seoul, Seoul-t'ukpyolsi, South Korea |
IDFC-Parampara Fund | India, Maharashtra, Mumbai |
Maxula Seed Fund | Gabès, Tunis, Tunisia |
NFX Ventures | - |
NXChain Inc | California, Tustin, United States |
Peak Ventures | Lehi, United States, Utah |
Revera Home Health Business | - |
Roclink Capital | Canada, Ontario, Toronto |
S-Equity Partner | - |
SIAR Capital | New York, New York, United States |
Sony Electronics | California, San Diego, United States |
Venture Frogs | California, San Francisco, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Visen Pharmaceuticals | $150M | 08 Jan 2021 | Shanghai, China | ||
Visen Pharmaceuticals | $40M | 13 Nov 2018 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Visen Pharmaceuticals | $150M | 08 Jan 2021 | Shanghai, China | ||
Visen Pharmaceuticals | $40M | 13 Nov 2018 | Shanghai, China |